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This analysis uses two main data sources to explore frequent 
and high-risk cannabis use in Europe. First, general population 
surveys provide data on frequency of cannabis use. Secondly, 
data collected by specialised drug treatment centres on 
clients entering treatment for problems primarily related 
to cannabis use give insight into the personal and social 
characteristics of this group of users, a high proportion of 
which may be engaging in high-risk patterns of cannabis use. 
Additional information is derived from the literature.
I  Frequent and high-risk cannabis use in Europe: prevalence of the phenomenon
Any description of intensive forms of cannabis use is 
complicated by a lack of consensus on the terminology. For 
monitoring purposes, the EMCDDA uses ‘daily or near-daily 
use’ (use on 20 days or more in a month), which is also 
referred to as ‘frequent cannabis use’. High-risk cannabis 
use is defined as ‘cannabis use disorder’, as described in the 
current international diagnostic manuals (i.e. ICD and DSM). 
This includes, in particular, cannabis dependence. 
The most recent EMCDDA estimate suggests that there are 
around 3 million daily cannabis users in Europe (EMCDDA, 
2012). Additional information can be found in youth surveys 
which monitor the prevalence of more intensive cannabis use 
(40 or more times in life) in 15- to 16-year-old school students. 
Prevalence of intensive use in this group ranges from 0.3% to 
8%, depending on the country .
Cannabis is Europe’s most commonly 
used illicit drug, with approximately 
20 million adults, or around 6% of the 
population aged 15–64 years, having used 
the drug in the last year. An indication 
of the public health impact of the drug 
can be seen in the numbers entering 
specialised treatment in Europe for drug-
related problems, among whom cannabis 
is the second most frequently reported 
drug, after heroin. Against this backdrop, 
identifying the characteristics of frequent 
and high-risk cannabis users can help 
with the identification and design of 
interventions for those cannabis users 
most at risk of experiencing problems. 
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Data on users entering drug treatment for cannabis-related 
problems can also shed some light on high-risk cannabis 
use in Europe. Among clients who entered drug treatment 
for the first time in their life in 2011, cannabis use is the 
most frequently cited reason – and has been since 2008. 
The number of first-time cannabis clients has risen markedly, 
mainly since 2008. Currently, cannabis clients represent 
around half or more of all clients entering drug treatment 
in five countries (France, Denmark, Cyprus, Hungary and 
the Netherlands). Country differences in levels of treatment 
demand need to be interpreted with caution, however, 
and may reflect differences in treatment provision, referral 
practices, legislation, in addition to the prevalence of intensive 
cannabis use. For example, referrals from the criminal justice 
system may blur the picture by introducing into the treatment 
system cannabis users with less frequent patterns of use.
I  Males particularly over-represented among frequent and high-risk cannabis users
Males are generally over-represented among cannabis users, 
and their share in the cannabis-using population has what 
is known as a ‘dose-dependent relationship’ with frequency 
of use and related problems. This means that the proportion 
of males increases with frequency of cannabis use, and is 
highest among those with problems related to cannabis 
(here represented by users entering treatment). So, while 
approximately 70% of last year cannabis users are male, the 
proportion of males rises to 75% among last month users, 
78% among daily users in the last month and 84% among 
treatment entrants reporting cannabis as their primary drug 
(see Table 1). Over-representation of males among users is 
typical for illicit drugs; however, cannabis clients present one 
of the highest ratios of males to females among drug clients 
entering treatment. Although there is some variation between 
countries, all report that three-quarters or more of cannabis 
treatment entrants are male.
Table 1: Gender breakdown according to frequency of 
cannabis use among adults (15–64 years) and treatment 
entrants reporting cannabis as their primary drug 
Use of 
cannabis at 
least once 
in the last 
year
Use of 
cannabis 
at least 
once in 
the last 
month
Daily 
cannabis  
users
Cannabis 
users 
entering 
treatment 
(1)
Male 70% 75% 78% 84%
Female 30% 25% 22% 16%
(1) Age range among treatment entrants might be slightly broader than    
15–64 years. 
Source: EMCDDA Statistical bulletin, 2013.
The literature highlights a number of important issues for 
women with daily or dependent cannabis use: for example, 
these women are significantly more likely to have a cannabis-
using partner, but less likely to have a heavy cannabis-using 
social network. With similar patterns of cannabis use, 
they have greater concern about their cannabis use and 
perceived difficulty of quitting (Copeland et al., 2001; Swift 
et al., 2000). Males with similar patterns of use, in contrast, 
tend to have higher levels of alcohol and tobacco use, more 
criminal convictions and higher levels of psychosocial distress 
(Copeland et al., 2001).
I  Cannabis clients among the youngest in treatment
Frequent and high-risk cannabis users tend to be young 
people (below 35 years of age). Of the estimated 3 million 
European daily cannabis users, roughly 70% are aged between 
15 and 34, and over 86% of clients entering treatment in 
Europe with cannabis as their primary drug are aged 34 or 
less. The estimated mean age of clients entering treatment 
for cannabis use is 25 years, which is one of the lowest mean 
ages among the different groups of drug clients.
Populations of older cannabis users do exist. Studies available 
on users who have been using the drug for 10 or more years 
(on average 19) suggest that they may have established a 
routine of cannabis use that is less intensive than that of 
younger frequent users. Various reasons are suggested to 
explain why older users may feel less inclined to discontinue 
their cannabis smoking: for example, they may perceive more 
benefits than risks from their use or experience less social 
pressure to stop (Korf et al., 2007; Reilly et al., 1998). As a 
consequence, this group may be less likely to contact services, 
even though problems such as cannabis dependence are not 
uncommon among these users (Swift et al., 2000).
The majority of frequent cannabis users will have started 
to use the drug while they were in their teens. The age at 
first use is negatively related to the level of harm potentially 
experienced by the user. Early initiation and regular cannabis 
use during adolescence have been found to be associated 
with numerous negative outcomes, including problematic 
patterns of cannabis use, use of other illicit drugs, mental 
health problems and low educational achievement (Copeland 
and Swift, 2009; Fischer et al., 2011). It is important not to 
infer that early cannabis use causes all the above-mentioned 
harms, as there are numerous common and overlapping risk 
factors and life experiences that may explain this association.  
I  Socio-economic status: diverse findings 
Data on the socio-economic status of frequent cannabis users 
are scarce and sometimes contradictory. A recent Dutch study 
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(van der Pol et al., 2013) found frequent cannabis users to 
have, on average, a higher level of educational attainment 
than the general population; however, they were more often 
unemployed or unable to work. In two Australian studies 
(Copeland et al., 2001; Reilly et al., 1998), community samples 
of heavy or long-term cannabis users had levels of educational 
attainment and employment similar to or higher than those 
of the general population. A 2012 analysis of EU treatment 
demand data found that most cannabis users entering 
treatment were living in stable accommodation (60–90%). 
Depending on the country, somewhere between one-third 
and two-thirds had completed at least secondary education, 
while between 40% and 60% were in full-time education or 
employment. Unemployment among primary cannabis users 
entering treatment ranged from 7% to 40%.
A recent study among French adolescents supports the view 
that higher socio-economic status has a protective effect 
against daily cannabis use (Legleye et al., 2011). Findings 
suggest that although young people from families with higher 
socio-economic status had higher risk of experimental use of 
cannabis, they were also less likely to engage in daily use of 
the drug.
I  Conclusion
This exploration of the evidence on the characteristics of 
frequent cannabis users supports the findings of studies 
which identify young males as a population group that is 
over-represented among frequent cannabis users. Among 
frequent and daily users of cannabis, dependence is a 
concern and may help to explain some of the variation that 
exists in patterns of use, mental health and cannabis-related 
problems (see box ‘Characteristics of frequent cannabis 
users with and without dependence’). With regard to the 
design of appropriate interventions for users most at risk of 
experiencing problems, evidence presented here suggests 
that these should be suited to predominantly young male 
populations with high levels of cannabis-related problems, 
poly-drug use patterns and likely mental health problems. 
Treatment options should take into account the significant 
minority of women among those with cannabis problems, 
as they may have different needs. Looking towards the 
future, treatment services may see growing numbers of 
older cannabis users, if a sizeable proportion of the current 
relatively large population of frequent cannabis users continue 
to use the drug intensively as they age.
I  Facts and figures 
20 million have used the drug in the last year.
11 million have used cannabis in the last month.
3 million have used the drug daily or almost daily in the 
last month. 
More than three-quarters of all reported drug law offences 
in the European Union are related to cannabis, and this 
figure has been increasing since 2006.
In about two-thirds of the EU Member States, the 
cannabis market is dominated by herbal cannabis; 
cannabis resin dominates in the other Member States.
The typical (modal) potency and price of cannabis ‘products’ 
varies widely among EU Member States, with potency 
(%THC) ranging from approximately 1% to 15%, and price 
from EUR 5 to EUR 15 per gram.
Cannabis use can cause adverse health effects, both acute 
and chronic. Of the acute effects, an increased risk of being 
involved in motor vehicle accidents is one of the most 
serious consequences. Chronic effects include dependence, 
respiratory diseases and psychotic symptoms. Risks to 
health generally increase with early onset and increasing 
frequency of use and quantity used.
Cannabis dependence is usually diagnosed in Europe 
according to the World Health Organization’s International 
Classification of Diseases, 10th revision. It can be described 
as ’a cluster of behavioural, cognitive, and physiological 
phenomena that develop after repeated substance use 
and that typically include a strong desire to take the drug, 
difficulties in controlling its use, persisting in its use despite 
harmful consequences, a higher priority given to drug use 
than to other activities and obligations, increased tolerance, 
and sometimes a physical withdrawal state’.
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A small number of studies have looked into the concept 
of cannabis dependence, comparing frequent (1) or daily 
cannabis users with and without dependence (Looby and 
Earleywine, 2007; van der Pol et al., 2013), or populations 
with self-perceived treatment need to populations without 
this perception (Copeland et al., 2001). Depending on the 
population studied, somewhere between 25% and 50% of 
daily cannabis users will fulfil the criteria for dependence 
(NIDA, 2012). A general conclusion that can be drawn 
from these studies is that, while frequent to daily use of 
cannabis is a strong predictor of cannabis-related problems 
(Fischer et al., 2011), these accumulate even more in users 
with (probable) dependence.  
 
Although the above-mentioned studies have found relatively 
small differences in the frequency or intensity of use or 
quantity of cannabis used between dependent and non-
dependent frequent or daily users, marked differences were 
identified between dependent and non-dependent users in 
the levels of cannabis-related problems experienced, use 
of other substances and mental health problems. Other 
characteristics more prevalent in dependent users included 
solitary use and use in order to cope with problems. 
 
In a recent study among a sample of Dutch cannabis users, 
frequent users (with and without dependence) had a higher 
prevalence of externalising disorders such as childhood 
and adult attention deficit-hyperactivity disorder or conduct 
disorder (van der Pol et al., 2013). This association was 
stronger in those with cannabis dependence. They had, in 
addition, an increased prevalence of internalising disorders, 
such as depression or anxiety disorder. These mental health 
problems are often preceded by childhood adversity, and 
factors such as loss of parent or child abuse were relatively 
common in both groups, and more common than in the 
general population. 
 
Childhood adversity, however, did not explain the 
differences in mental health between dependent and 
non-dependent users. The authors concluded that there 
must be other, personality-related, genetic or environmental 
vulnerability factors that play a role. It is probable that these 
factors are involved both in mental health problems and 
cannabis dependence. 
 
(1) Frequent cannabis use was defined in the study of van der Pol et al. 
(2013) as use of the drug on 12 or more days a month in the past year.  
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Interactive map: regular and frequent cannabis users available on the EMCDDA 
website: emcdda.europa.eu/topics/pods/frequent-cannabis-users
I  Interactive element: map
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